Herceptin Biosimilar Market - (By Application - Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma Market By End Users- Hospital & Clinics, Oncology Centers)- Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 150


Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein. In 2014, herceptin has lost the patent in Japan and Europe which has opened the gates for the development of the biosimilar to enter the market.  Whereas, the patent for the drug in U.S. will expire in 2019. The companies are continuously trying to introduce the new generic drugs to expand their market.

Market Dynamics

During last few years, there is a significant rise in the cancer patient pool. Increasing prevalence of the cancer and increasing demand for the targeted therapy have led to drive the growth of the market. Breast cancer is the most widely occurred cancer in the woman. According to the U.S. breast cancer Statistics, over 12.4% of the total American woman develops breast cancer in their lifetime. Changing lifestyle, increasing pollution and adoption of smoking by the people has fuelled the growth of the market. As there are huge opportunity for the development of the cancer drug a number of companies are continuously investing a huge amount of capital in research and development. Increasing spending on research & development and increasing demand for the better drugs for the treatment has supported and created a huge opportunity in coming future.

On the other hand, availability of the alternative treatment and huge side effects of the drugs may slow the growth of the market during the forecasted period.

Market Classification and Overview

The global herceptin biosimilar market is segment into application, end-user, and region.

On the basis of application, the market is segmented into breast cancer, colorectal cancer, leukemia, lymphoma, and others.

Based on the end-user, the market is segmented into hospital & clinics, oncology centers, and others.

Regional Overview

Geographically, the global herceptin biosimilar market is segmented into : North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

Europe dominates the global herceptin biosimilar market owing to the patent expiry of the drug in Europe. In 2014, herceptin biosimilar has lost the patent which has increased the market for the generics of the herceptin. Additionally, introduction of the new generics products in European market and continuous research & development in the drug discovery has boosted the growth of the market in Europe. Asia Pacific holds the second position followed by America. The Asia Pacific herceptin biosimilar market is majorly driven by rapid adoption of the herceptin biosimilar, increasing awareness about the generic products, and huge patient pool. Japan is expected to hold the major share in the market owing to the patient expiry of herceptin in 2014. However, LAMEA holds the last position in the market owing to the limited spending on the healthcare and Research & Development.

Report Coverage


Herceptin Biosimilar Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year


Forecast Data

2018 – 2026

Market Stratification

 Application, End Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The global herceptin biosimilar market comprises of some of the major players such as

  • Mylan
  • Biocon
  • Roche
  • others

Currently limited numbers of companies are present in the market. Herceptin was developed by Roche and is still holding the patient in some of the countries. However, the companies like Pfizer, TEVA and others are continuously trying to develop the new generic drugs so as to enter in the market. With the expiry of the patent for the drug in 2019, the herceptin biosimilar market will possess a huge growth.

Market Segmentation

Market By Application

  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Lymphoma
  • Others

Market  By End-User

  • Hospital & Clinics
  • Oncology Centers
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Wound Dressing Market (By Product - Traditional, Advanced [Moist, Foam, Alginate, Film, Hydrocolloid, Hydrogel], Antimicrobial [Silver, Non - Silver], Interactive [ Biomaterials, Skin - Substitute]) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Moisture wound dressing is a clinical technique to create a moist around the wound in order to speed up the healing process and reduce scabs and scarring for beautiful skin. Moisture wound dressing promotes the growth and migration of new cells and also maintains the proteins that are essential for wound closure. The report provides analysis of global moisture wound

Infection Surveillance Solutions Market (By Product and Services - Software [ On-premise, Web-based], Services; By Infection Type - Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use - Long Term Care Facilities, Hospitals, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare associated Infections (HAIs), or nosocomial contaminations, are the measure of the patient prosperity and health concerns coming about because of poor cleanliness, diminished patient immunity, carelessness and extra medicinal services uses. Infection surveillance is designed to constantly monito

Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Hematology is a part of drug, which manages the study of blood, blood illnesses and blood-forming organs. Hematology incorporates issues related with white platelets, red platelets, bone marrow, lymph, and platelets. It additionally influences the fluid part of blood known as plasma. Hematology incorporates different IVD advancements, such as blood analysis, stream

Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare contract research organization (CRO) provides support and services as biologic assay development, clinical research, commercialization, preclinical research, clinical trials management and biopharmaceutical development to biotechnology, pharmaceutical and medical device industries. Healthcare co

Antibiotic Resistance Market (By Disease - cUTI, cIAI, BSI, CDI, ABSSSI, HABP/VABP, CABP; By Pathogen - Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, E. coli/K. Pneumoniae, Streptococcus Pneumoniae, Clostridium difficile, Enterococcus faecium, Haemophilus Influenzae; By Drug Class - Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause

Sterility Indicators Market (By Type - Chemical Indicators, Biological Indicators; By Technique - Heat Sterilization, Low Temperature Sterilization, Filtration, Sterilization, Radiation Sterilization, Liquid Sterilization; By End-user - Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical, laboratories/Research Centers, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global sterility indicators market was valued at USD 547.5 million in 2017 in terms of revenue. It is expected to grow at a CAGR of 10.8% during the forecast period. Stringent regulations regarding healthcare products and greater emphasis on sterility parameters and methods for the prevention of Hospital Acquired Infections are anticipated to dr

Cart Summary